Long Term Evolution (LTE) technology is ahead in the race as the most sought-after next-generation (4G) wireless network standard in the market. The 4G wireless networks are aiming to cope with substantial demand for high-speed wireless data services and mobile video. LTE is an IP-based modulation standard and a set of enhancement for the existing Universal Mobile Telecommunications System (UMTS). This technology has been pioneered by the 3rd Generation Partnership Project (3GPP), a telecom industry body comprising wireless carriers and equipment vendors who have been buying and selling the same proprietary products for years. Verizon Communication (VZ), the largest carrier in the U.S., and NTT DoCoMo (DCM), the largest carrier in Japan, are the first two companies to decide on implementing LTE–based networks by 2010. Vodafone (VOD), the largest mobile carrier globally on revenue count and AT&T (T) will implement LTE by ...

DrStockPick.com Stock Report!

Tuesday September 15, 2009

**************************************************************

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained favorable results from recently completed Phase 1 studies of LX4211 and announced today that it has initiated a Phase 2 clinical trial of the drug candidate in patients with type 2 diabetes mellitus. LX4211 is an orally-delivered, small molecule drug candidate that inhibits the sodium glucose transporter 2 (SGLT2). LX4211 is Lexicon’s fourth drug candidate currently being tested in Phase 2 clinical trials.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Medtronic, Inc. (NYSE: MDT),

...

 

PennyOmega.com Hot Stock News & Alerts!

________________________________________

FREE Daily Stock Alerts From PennyOmega.com

________________________________________

 

Thursday September 3, 2009

PennyOmega.com Stock Report!

**************************************************************

YRC Inc., a subsidiary of YRC Worldwide Inc. (Nasdaq: YRCW), announced today additional enhancements to their suite of Expedited Precision services. New Fastest Ground service options make it easier and less time consuming for customers to expedite time-sensitive shipments by eliminating the need to supply delivery dates every time expedited shipping

...

Long Term Evolution (LTE) technology is ahead in the race as the most sought-after next-generation (4G) wireless network standard in the market. The 4G wireless networks are aiming to cope with substantial demand for high-speed wireless data services and mobile video.  Verizon Communication (VZ), the largest carrier in the U.S, NTT DoCoMo (DCM), the largest carrier in Japan, and TeliaSonera AB (TLSN) of Sweden are the first three companies who have decided to implement LTE-based networks by 2010. Vodafone Plc (VOD), the largest mobile carrier globally on revenue count and AT&T (T) will implement LTE by 2012. China Mobile (CHL), the largest wireless operator globally on subscriber count has also decided to opt for 4G LTE technology.

The growing acceptance of LTE technology has prompted the mobile handset makers to develop phones that will be compatible with this network. NTT DoCoMo will launch LTE handsets

...

PetroAlgae, an emerging renewable energy company, today issued a Special Letter to Shareholders. The letter updates the investment community on the current status of the company and its future growth outlook. The entire letter is posted below:

“Dear Fellow Shareholder,

As an investor in PetroAlgae Inc. (OTCBB: PALG), you have joined a select group of forward-looking people who understand the potential of micro-crops as one of the most viable new sources of clean, renewable feedstocks in the petroleum and biofuels industries. Moreover, you have delivered a vote of confidence in a company with technologies that we believe are on the brink of producing new and substantial revenue streams. For that we thank you, and we pledge to keep your interests paramount. In response to your support for PetroAlgae and your interest in our industry, we intend to communicate with you on a regular basis through letters such as these, among

...

Highlights include Sanofi-Aventis SA (SNY) and Johnson & Johnson (JNJ).On March 18th and 19th, the FDA advisory panels recommended approval of 2 important cardiovascular product candidates. The FDA does not have to follow the recommendations of the panels but usually does.On Wednesday, the 18th of March, an FDA advisory panel recommended approval of Sanofi-Aventis' (SNY) heart drug Multaq. Multaq (dronedarone) is a new class III anti-arrhythmic drug developed for atrial fibrillation (AF).On Thursday the 19th, an FDA review panel voted 15 to 2 in favor of approving Johnson & Johnson's (JNJ) anticoagulant rivaroxaban. Rivaroxaban, which will be sold under the brand name Xarelto upon approval, will be marketed in the U.S. by J&J and is already sold partner Bayer AG outside of the U.S. Multaq was initially submitted to the FDA for approval in 2006 but the FDA responded ...